Explore: Biotech · Drug Discovery · Diagnostics · Digital Health · Pre-Seed · Seed
Criteria Bio Ventures
Criteria Capital Risc
Investment Thesis
Identifying, financing and supporting innovative companies developing new therapies with the potential to transform treatment of diseases and improve people's lives.
About Criteria Bio Ventures
Criteria Bio Ventures is the evergreen Life Sciences venture capital arm of CriteriaCaixa, dedicated to investments in the Life Sciences. With over 20 years of VC experience, we leverage our strong legacy and commitment to society and healthcare to support innovative companies that are tackling vital therapeutic challenges.
Sectors
Stages
Geographic focus
Team
| Pablo Cironi | Director |
| Salvatore Cappadona | Principal |
| Sebastián Chiavenna | Principal |
| Alejo Chorny | Principal |
| Juan-Pablo Bartra | Finance Operations Manager |
| Beltrán Vives | In-house Lawyer |
| Mireia Pasalamar | Management Assistant |
Notable Investments
Northern Biologics, Minoryx Therapeutics, Aboleris Pharma, Sanifit Therapeutics
Verified 13 July 2026 · Sources: company website, Fusion42 review
Frequently asked questions
- What does Criteria Bio Ventures invest in?
- Criteria Bio Ventures invests in Biotech, Drug Discovery, Diagnostics, Digital Health and Medtech at the pre-seed and seed stages.
- Which geographies does Criteria Bio Ventures focus on?
- Criteria Bio Ventures focuses on Spain, Portugal, Europe and North America, and is headquartered in Spain.
- What is Criteria Bio Ventures's typical check size?
- Criteria Bio Ventures typically writes checks of $1M to $10M.